A Buckingham business is offering free face visors to other businesses who might be working out how to bring employees safely back to the workplace.
BCQ, based in Buckingham on Swan Business Park, is giving away a limited number of PPE visors to businesses based in Buckingham and the surrounding area in return for a donation to its charity partner, Brain Tumour Research.
The company, which offers print production, mailing and creative services, has had a long association with Brain Tumour Research, handling its printing and mailing requirements since the charity was first launched in Padbury in 2009. A team of employees regularly take part in the annual On Yer Bike for brain tumours campaign which takes place across the UK, including at Swan Pool in Buckingham, in February.
Chris Knowles, MD at BCQ said: “We are conscious that organisations are trying to work out their plans for returning to work and looked to see what we could do to help.
“We have produced a limited supply of PPE visors which meet the BSI’s PPE for healthcare professionals 2020/403 eye protection technical specification. These are available at no cost on a collection only basis. As well as schools, a number of businesses have already been in touch including manufacturing and medical. All we ask in return is a donation to Brain Tumour Research because, like many charities in the current pandemic, their income is in jeopardy. Brain tumours kill more children and adults under the age of 40 than any other cancer and is a disease which has affected staff at BCQ.”
Brain Tumour Research spokesman Hugh Adams said: “We are very grateful to Chris and everyone at BCQ for this amazing gesture and for raising awareness – some 16,000 people are diagnosed with a brain tumour every year and, despite the fact they kill more children and adults under the age of 40 than any other cancer, historically, just 1% of the national spend on cancer research has been allocated to this devastating disease.
“Like many organisations the coronavirus pandemic has meant a massive financial hit for us, particularly with the cancellation and/or postponement of challenges like the London Marathon, and we are anticipating a loss of 50% of income in just three months. We would like to thank BCQ and all our supporters who are helping us through these difficult times.”
Brain Tumour Research funds sustainable research at dedicated centres in the UK. It also campaigns for the Government and the larger cancer charities to invest more in research into brain tumours in order to speed up new treatments for patients and, ultimately, to find a cure. The charity is calling for a national annual spend of £35 million in order to improve survival rates and patient outcomes in line with other cancers such as breast cancer and leukaemia and is also campaigning for greater re-purposing of drugs.
To request free PPE visors subject to availability go to bcqgroup.com/btr
Only one request for visors per person and per company.
About Brain Tumour Research
Brain Tumour Research was launched in 2009 by Padbury resident, Sue Farrington Smith MBE who lost her niece to a brain tumour three weeks before her eighth birthday in 2001.
Horrified by the lack of funding into research of the devastating disease which kills more children and adults under the age of 40 than any other cancer, Sue had already co-founded Ali’s Dream with the objective of raising funds for research into childhood brain tumours.
Move forward 11 years, and with fundraising at circa £4million a year, Brain Tumour Research has moved from its humble beginnings in a converted cow shed, on Sue’s farm in Padbury, to offices in Milton Keynes. The charity is transforming research into brain tumours in the UK through a strategy of setting up Centres of Excellence and is building capacity in pioneering research which allows the centres to attract other funding as a result of our own investment.
Our campaigning successes have shone a spotlight on the historic underfunding and have led to increased national investment in research into brain tumours.
We are determined to make a difference and continue to fund the fight and find a cure for this devastating disease.
The next decade is set to see huge advances in our quest to improve outcomes for patients and their families as we seek to grow capacity, build infrastructure, accelerate treatments and increase national investment in brain tumour research to £35 million a year by 2025.